Peter Attia MD323 - CRISPR and the future of gene editing: scientific advances, genetic therapies, & more
At a glance
WHAT IT’S REALLY ABOUT
Feng Zhang Explains CRISPR's Origins, Therapies, Delivery Hurdles, and Ethics
- Zhang describes how his optogenetics work at Stanford exposed the need for precise gene editing, and how he came to CRISPR after zinc finger nucleases and TALENs proved cumbersome.
- He explains CRISPR as a bacterial adaptive immune system in which viral snippets stored between repeats guide Cas proteins to cut invading DNA, with the PAM sequence preventing self-targeting.
- Current therapies such as sickle cell treatment, liver editing and eye treatments show progress, but Zhang says delivery, not the editing payload, is the main bottleneck, along with compact Cas proteins and large-gene insertion.
- He and Attia discuss the 2018 embryo-editing case, the germline debate, and why enhancing traits like intelligence is biologically complex and full of trade-offs.
- Zhang credits teachers and the American education system for his path and says he remains optimistic about science, citing AI, automation and faster data generation.
IDEAS WORTH REMEMBERING
5 ideasCRISPR is a programmable system, like a smartphone running different apps.
Zhang says zinc fingers and TALENs required building a new protein for each target, while CRISPR only needs a new, easily synthesized guide RNA to retarget Cas9.
Bacteria use CRISPR as an adaptive immune system with built-in memory.
Surviving bacteria store roughly 30-letter viral snippets between repeats, and on reinfection they make guide RNAs that direct Cas9 to cut the virus within minutes.
The PAM sequence keeps bacteria from cutting their own DNA.
The PAM sits next to the target in the viral genome but is not copied into the bacterial CRISPR array, and Cas9 needs it to cleave.
Delivery, not the editing payload, is the main bottleneck for genetic medicine.
Zhang says tools like Cas9, base editing, prime editing and epigenetic editing have advanced, but getting them into the right cells and tissues remains hard.
The approved sickle cell therapy uses a simple cut rather than repairing the mutation.
Editing a different gene to turn on fetal hemoglobin avoids needing template repair, and it works efficiently when cells are treated outside the body.
WORDS WORTH SAVING
5 quotesWith CRISPR, the promise is that CRISPR is like the smartphone. You can load software onto it to recognize different genes, and the software is the CRISPR RNA.
— Feng Zhang
The payload technology has come a long way. But the bottleneck is how do we put these really powerful payloads into the right cells in the right tissue in the body?
— Feng Zhang
You might make some mutations that make the person smarter, but that could also increase cancer risk, right? Or impair athletic capability. Or make a person live shorter.
— Feng Zhang
I am an optimist. I think that's the only way to be, because if you're not optimistic, then there's only downside.
— Feng Zhang
I think it's gonna accelerate science and medicine and human health beyond our imagination.
— Feng Zhang
High quality AI-generated summary created from speaker-labeled transcript.
